Real‐world safety profile of once‐weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real‐world Evidence (SURE) programme
Article in Diabetes Obesity and Metabolism (August 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Diabetes Obesity and Metabolism (August 2024)
Article in Asploro Journal of Biomedical and Clinical Case Reports (August 2024)